Efficacy of Cerebrolysin as an Adjuvant Therapy Following Mechanical Thrombectomy in Patients with Large Vessel Occlusion Stroke
Not Applicable
Recruiting
- Conditions
- Nervous System Diseases
- Registration Number
- PACTR202306562134107
- Lead Sponsor
- Ain Shams University hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients with acute cardioembolic stroke as defined by TOAST classification.
-Evidence of large vessel occlusion
-NIHSS =10,
- Underwent successful mechanical thrombectomy ± IV thrombolysis, after fulfilling the standard eligibility criteria.
Exclusion Criteria
-Patients aged more than 80 years old
-Patients with epilepsy
-Patients who are pregnant or lactating
-Patients serious, advanced, or terminal illness or life expectancy = 6 months
-Patients with bleeding tendency or platelet count less than 100,000/uL
-Patients with high INR above 1.7
-Patient receiving low molecular weight heparin therapy less than 24 hours of stroke onset.
-Patient with premorbid cognitive impairment
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method